US Bancorp’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.4M Sell
321,533
-1,073
-0.3% -$95.6K 0.03% 267
2025
Q4
$25.5M Sell
322,606
-14,187
-4% -$1.11M 0.03% 283
2025
Q3
$26.9M Sell
336,793
-14,529
-4% -$1.24M 0.03% 284
2025
Q2
$31.9M Sell
351,322
-10,916
-3% -$997K 0.04% 258
2025
Q1
$33.9M Sell
362,238
-25,728
-7% -$2.3M 0.05% 243
2024
Q4
$35.3M Sell
387,966
-1,998
-0.5% -$191K 0.05% 230
2024
Q3
$40.5M Sell
389,964
-4,328
-1% -$441K 0.05% 216
2024
Q2
$38.3M Sell
394,292
-9,759
-2% -$900K 0.05% 219
2024
Q1
$36.4M Sell
404,051
-9,706
-2% -$822K 0.05% 224
2023
Q4
$33M Sell
413,757
-8,347
-2% -$628K 0.05% 231
2023
Q3
$30M Sell
422,104
-11,579
-3% -$866K 0.05% 230
2023
Q2
$33.4M Buy
433,683
+24
+0% +$1.86K 0.05% 223
2023
Q1
$32.6M Sell
433,659
-14,875
-3% -$1.11M 0.06% 220
2022
Q4
$35.3M Sell
448,534
-92,757
-17% -$6.95M 0.06% 209
2022
Q3
$38M Sell
541,291
-15,882
-3% -$1.25M 0.08% 179
2022
Q2
$44.7M Buy
557,173
+4,355
+0.8% +$341K 0.09% 173
2022
Q1
$41.9M Sell
552,818
-355,392
-39% -$28.2M 0.07% 195
2021
Q4
$77.5M Sell
908,210
-7,716
-0.8% -$603K 0.12% 144
2021
Q3
$69.2M Sell
915,926
-7,641
-0.8% -$607K 0.13% 143
2021
Q2
$75.1M Sell
923,567
-21,691
-2% -$1.77M 0.14% 140
2021
Q1
$74.5M Sell
945,258
-18,523
-2% -$1.45M 0.15% 129
2020
Q4
$82.4M Sell
963,781
-23,351
-2% -$1.93M 0.18% 117
2020
Q3
$76.2M Sell
987,132
-10,108
-1% -$771K 0.19% 115
2020
Q2
$73.1M Sell
997,240
-14,709
-1% -$1.04M 0.19% 115
2020
Q1
$67.2M Sell
1,011,949
-2,658
-0.3% -$187K 0.21% 104
2019
Q4
$69.8M Sell
1,014,607
-41,574
-4% -$2.83M 0.18% 121
2019
Q3
$77.6M Sell
1,056,181
-63,599
-6% -$4.61M 0.21% 106
2019
Q2
$80.3M Buy
1,119,780
+346,977
+45% +$24.6M 0.22% 99
2019
Q1
$53M Sell
772,803
-5,110
-0.7% -$330K 0.15% 131
2018
Q4
$46.3M Sell
777,913
-6,531
-0.8% -$409K 0.15% 134
2018
Q3
$52.5M Sell
784,444
-13,835
-2% -$922K 0.15% 133
2018
Q2
$51.7M Sell
798,279
-52,098
-6% -$3.41M 0.16% 128
2018
Q1
$61M Sell
850,377
-77,539
-8% -$5.58M 0.19% 116
2017
Q4
$70M Sell
927,916
-14,111
-1% -$1.03M 0.21% 108
2017
Q3
$68.6M Sell
942,027
-10,986
-1% -$792K 0.22% 107
2017
Q2
$70.6M Sell
953,013
-45,691
-5% -$3.39M 0.24% 102
2017
Q1
$73.1M Sell
998,704
-107,175
-10% -$7.5M 0.25% 99
2016
Q4
$72.4M Sell
1,105,879
-41,179
-4% -$2.82M 0.26% 96
2016
Q3
$85M Sell
1,147,058
-10,623
-0.9% -$785K 0.32% 80
2016
Q2
$84.7M Sell
1,157,681
-16,218
-1% -$1.15M 0.32% 79
2016
Q1
$82.9M Sell
1,173,899
-89,805
-7% -$5.97M 0.33% 81
2015
Q4
$84.2M Buy
1,263,704
+196,681
+18% +$13.1M 0.34% 76
2015
Q3
$67.7M Sell
1,067,023
-44,892
-4% -$2.93M 0.28% 87
2015
Q2
$72.7M Sell
1,111,915
-14,682
-1% -$996K 0.28% 81
2015
Q1
$78.1M Sell
1,126,597
-9,620
-0.8% -$665K 0.3% 80
2014
Q4
$78.6M Sell
1,136,217
-39,951
-3% -$2.7M 0.3% 78
2014
Q3
$76.7M Buy
1,176,168
+14,993
+1% +$989K 0.31% 69
2014
Q2
$79.2M Buy
1,161,175
+4,256
+0.4% +$285K 0.32% 65
2014
Q1
$75M Buy
1,156,919
+1,329
+0.1% +$83.7K 0.31% 69
2013
Q4
$75.4M Buy
1,155,590
+1,897
+0.2% +$121K 0.31% 69
2013
Q3
$68.4M Sell
1,153,693
-25,198
-2% -$1.49M 0.3% 72
2013
Q2
$67.5M Buy
+1,178,891
New +$70M 0.31% 68

Other funds holding CL

US Bancorp's CL Position: Q1 2026 in Review

US Bancorp reduced its Colgate-Palmolive (CL) stake by 0.33% in Q1 2026, selling an estimated $95.6K and leaving 321,533 shares worth $27.4M. The position accounts for 0.03% of the portfolio, ranked #267.

US Bancorp first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $85M in Q3 2016. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • US Bancorp held 321,533 shares of Colgate-Palmolive worth $27.4M as of Q1 2026.
  • US Bancorp sold 1,073 Colgate-Palmolive shares in Q1 2026, an estimated $95.6K.
  • Colgate-Palmolive made up 0.03% of US Bancorp's portfolio in Q1 2026, its #267 holding.
  • US Bancorp first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • US Bancorp's Colgate-Palmolive position peaked at $85M in Q3 2016.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.